8-K: Green Thumb Industries Reports Record Revenue and Adjusted EBITDA for Q4 and Full Year 2024

Green Thumb Industries announces strong financial results for Q4 and full year 2024, marked by record revenue and adjusted EBITDA.

Summary

• Green Thumb Industries reported its financial results for the quarter and year ended December 31, 2024.
• Fourth quarter revenue reached $294 million, a 6% increase year-over-year.
• The company's GAAP net income for the quarter was $13 million, or $0.05 per basic share and $0.04 per diluted share.
• Adjusted EBITDA for the quarter was $98 million, representing 33% of revenue.
• For the full year, revenue totaled $1.1 billion, an 8% increase compared to the previous year.
• Full year GAAP net income was $73 million, or $0.31 per basic share and $0.30 per diluted share.
• Adjusted EBITDA for the year was $371 million, or 33% of revenue, a 14% increase year-over-year.
• The company repurchased approximately 3.9 million subordinate voting shares for $43 million during the year.
• Green Thumb opened ten RISE Dispensaries during the year, bringing the total to 101 retail locations nationwide.
• As of December 31, 2024, the company had $172 million in cash and cash equivalents.

Sentiment

Score: 9

Explanation: The document presents a highly positive outlook with record financial results, strategic growth initiatives, and optimistic management commentary, indicating strong confidence in the company's future performance.

Positives

• Revenue increased by 6% in Q4 2024 compared to the prior year period, reaching $294 million.
• GAAP net income increased to $13 million in Q4 2024, up from $3.2 million in the prior year period.
• Adjusted EBITDA increased to $98 million in Q4 2024, up from $90.8 million in the prior year period.
• Full year revenue increased by 8% to $1.1 billion.
• Full year GAAP net income increased to $73.1 million, up from $36.3 million in the prior year.
• Full year Adjusted EBITDA increased to $371.3 million, up from $325.8 million in the prior year.
• The company has a strong balance sheet with $172 million in cash.
• Gross profit for the fourth quarter was $158.1 million or 53.7% of revenue, up from $142.7 million or 51.3% of revenue over the prior year period.
• For the full year, gross profit was $601.1 million or 52.9% of revenue, up from $526.5 million or 49.9% in 2023.

Negatives

• Fourth quarter comparable sales decreased 2.6% versus the prior year on a base of 84 stores.
• Total selling, general and administrative expenses for the fourth quarter were $101.0 million or 34.3% of revenue, compared to $92.3 million or 33.2% of revenue for the fourth quarter 2023.
• Total selling, general and administrative expenses for the full year 2024 were $376.7 million or 33.1% of revenue, compared to $341.9 million or 32.4% of revenue in the prior year, primarily due to increased compensation costs during the year.
• The increase in retail revenue was partially offset by continued price compression in certain markets.

Risks

• Cannabis remains illegal under U.S. federal law, and enforcement of cannabis laws could change.
• State regulation of cannabis is uncertain.
• The company faces intense competition from both legal and illicit markets.
• The company is subject to unfavorable tax treatment as a cannabis business.
• The company faces risks related to its information technology systems and potential cyber-attacks and security breaches.

Future Outlook

The company is confident that its focus on capital allocation, operational excellence, product quality, and brand resonance will drive future success.

Management Comments

• Green Thumb Founder, Chairman and Chief Executive Officer Ben Kovler stated that demand for THC in America is at an all-time high and Green Thumb is well-positioned to deliver on this opportunity.
• Green Thumb President Anthony Georgiadis stated that the company made tremendous progress elevating brand awareness by connecting consumers to unique and memorable experiences.

Industry Context

The announcement highlights the growing demand for cannabis in the U.S., contrasting it with negative trends in alcohol consumption, suggesting a shift in consumer preferences towards cannabis for well-being.

Comparison to Industry Standards

• Comparing Green Thumb's adjusted EBITDA margin of 33% to peers like Curaleaf and Trulieve, which have historically reported margins in the 25-35% range, suggests Green Thumb is performing competitively.
• The company's revenue growth of 8% year-over-year is in line with the overall growth of the cannabis market, but specific comparisons to competitors would require further analysis of their respective growth rates.
• Green Thumb's focus on brand partnerships, such as with Barstool Sports and Magnolia Bakery, mirrors strategies employed by other cannabis companies to increase brand awareness and market share.

Stakeholder Impact

• Shareholders will likely react positively to the strong financial results and share repurchase program.
• Employees can benefit from the company's growth and expansion.
• Customers will have access to more RISE Dispensaries and a wider range of cannabis products.
• The company's growth can positively impact the communities in which it operates through job creation and charitable donations.

Next Steps

• Green Thumb will host a conference call on February 26, 2025, to discuss the results.
• The company will continue to focus on capital allocation, operational excellence, product quality, and brand development.

Key Dates